Structurally altered Evi-1 protein generated in the 3q21q26 syndrome

Oncogene

Volumn 13, Issue 1, 1996, Pages 183-191

  Ogawa, Seishi ^a   Kurokawa, Mineo ^a   Tanaka, Tomoyuki ^a   Mitani, Kinuko ^a   Inazawa, Johji ^b   Hangaishi, Akira ^a   Tanaka, Kozo ^a   Matsuo, Yoshinobu ^c   Minowada, Jun ^c   Tsubota, Teruhiko ^d   Yazaki, Yoshio ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^d Okayama Citizens Hospital   (Japan)

Author keywords

3q21q26; Blastic crisis; Evi 1; inv (3)(q21q26); Syndrome CML

Indexed keywords

ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL STRAIN 3T3; CHROMOSOME 3Q; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 3; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRON; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURAL CHROMOSOME ABERRATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLAST CRISIS; CELL LINE, TRANSFORMED; CHROMOSOMES, HUMAN, PAIR 3; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRONS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOID, CHRONIC; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; SYNDROME; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 8944258919     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, Copeland NG and Ihle JN. (1989). Oncogene, 4, 529-534.
2. Bitter MA, Neilly ME, Le BM, Pearson MG and Rowley JD. (1985). Blood, 66, 1362-1370.
3. Bordereaux D, Fichelson S, Tambourin P and Gisselbrecht S. (1990). Oncogene, 5, 925-957.
4. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
5. Dreyfus F, Bouscary D, Melle J, Ribrag V, Guesnu M and Varet B. (1995). Leukemia, 9, 203-205.
6. Fichelson S, Dreyfus F, Berger F, Melle J, Bastard C, Miclea JM and Gisselbrecht S. (1992). Leukemia, 6, 93-99.
7. Inazawa J, Saito H, Ariyama T, Abe T and Nakamura Y. (1993). Genomics, 17, 153-162.
8. Jenkins RB, Tefferi A. Solberg LJ and Dewald GW. (1989). Cancer Genet. Cytogenet., 39, 167-179.
9. Kreider BL, Orkin SH and Ihle JN. (1993). Proc. Natl. Acad. Sci. USA, 90, 6454-6458.
10. Kurokawa K, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte O and Hirai H. (1995). Oncogene, 11, 833-840.
11. Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN and Buckle VJ. (1994). Blood, 83, 1348-1354.
12. Matsuo Y, Adachi T, Tsubota T, Imanishi J and Minowada J. (1991). Hum. Cell., 4, 261-264.
13. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M and Hirai H. (1994). EMBO J, 13, 504-510.
14. Morishita K, Parganas E, Bartholomew C, Sacchi N, Valentine MB, Raimondi SC, Le BM and Ihle JN. (1990a). Oncogene Res., 5, 221-231.
15. Morishita K, Parganas E, Douglass EC and Ihle JN. (1990b). Oncogene, 5, 963-971.
16. Morishita K, Parganas E, Matsugi T and Ihle JN. (1992a). Mol. Cell. Biol., 12, 183-189.
17. Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB and Ihle JN. (1992b). Proc. Natl. Aacd. Sci. USA, 89, 3937-3941.
18. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG and Ihle JN. (1989). Cell, 54, 831-840.
19. Mucenski ML, Taylor BA, Copeland NG and Jenkins NA. (1988a). Oncogene Res., 2, 219-233.
20. Mucenski ML, Taylor BA, Ihle JN, Hartley JW, Morse HD. Jenkins NA and Copeland NG. (1988b). Mol. Cell. Biol., 8, 301-308.
21. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen BJ, Parganas E, Ihle JN and Rowley JD. (1994). Proc. Natl. Acad. Sci. USA, 91, 4004-4008,
22. Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y and Hirai H. (1996). Leukemia (in press).
23. Ogawa S, Toyoshima H, Kozutsumi H, Hagiwara K, Sakai R, Tanaka T, Hirano N, Mano H, Yazaki Y and Hirai H. (1994). Oncogene, 9, 1669-1678.
24. Ohyashiki JH, Ohyashiki K, Shimamoto T, Kawakubo K, Fujimura T, Nakazawa S and Toyama K. (1995). Blood, 85, 3713-3718.
25. Ohyashiki K, Ohyashiki JH, Fujieda H, Shimamoto T, Kawakubo K, Nakazawa S, Suzukawa K, Morishita K and Toyama K. (1994). Leukemia, 8, 2169-2173.
26. Rabbits T. (1994). Nature, 372, 143-149.
27. Russell M, Thompson F, Spier C and Taetle R. (1993) Leukemia, 7, 1654-1657.
28. Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, Asano S, Asou H, Kamada N, Yokota J and et al. (1994). Blood, 84, 2681-2688.
29. Tanaka T, Nishida J, Mitani K, Ogawa S, Yazaki Y and Hirai H. (1994). J. Biol. Chem., 269, 24020-24026.
30. Tanaka T, Suda T, Suda J, Inoue T, Hirabayashi Y, Hirai H, Takaku F and Miura Y. (1991). Blood, 77, 2597-2602.